We are live on
!
Find out more
JAM
JW Asset Management Portfolio holdings
AUM
$244M
1-Year Est. Return
71.51%
This Fund
S&P 500
This Quarter
Est. Return
-17.37%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$231M
AUM Growth
-$44M
(-16%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
98.6%
Holding
17
New
7
Increased
2
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vita Coco
COCO
|
+$9.23M |
| 2 |
NVIDIA
NVDA
|
+$6.72M |
| 3 |
Tesla
TSLA
|
+$2.7M |
| 4 |
Celsius Holdings
CELH
|
+$1.51M |
| 5 |
Caterpillar
CAT
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.21M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.95% |
| 2 | Consumer Staples | 11.33% |
| 3 | Technology | 2.83% |
| 4 | Consumer Discretionary | 1.14% |
| 5 | Industrials | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$2.7B
| $157M | 67.85% |
3,192,485
| – | – |
|
|
2
Celsius Holdings
CELH
$7.53B
| $17.2M | 7.43% |
300,000
+26,886
| +10% | +$1.51M |
|
3
Eli Lilly
LLY
$1.09T
| $14.5M | 6.28% |
27,000
| – | – |
|
|
NVO
4
Novo Nordisk
NVO
$225B
| $10.7M | 4.66% |
118,200
| – | – |
|
|
5
Vita Coco
COCO
$3.97B
| $9M | 3.9% |
+345,621
| New | +$9.23M |
|
|
CPRX
6
DELISTED
Catalyst Pharmaceutical
CPRX
| $6.59M | 2.85% |
563,392
| – | – |
|
|
7
NVIDIA
NVDA
$4.77T
| $6.52M | 2.83% |
+150,000
| New | +$6.72M |
|
|
8
Tesla
TSLA
$1.21T
| $2.63M | 1.14% |
+10,500
| New | +$2.7M |
|
9
Heron Therapeutics
HRTX
$92M
| $2.48M | 1.07% |
2,407,418
+200,000
| +9% | +$285K |
|
10
Idaho Strategic Resources
IDR
$456M
| $1.37M | 0.59% |
271,697
| – | – |
|
|
11
Caterpillar
CAT
$387B
| $1.1M | 0.48% |
+4,024
| New | +$1.09M |
|
12
Eaton
ETN
$150B
| $1.07M | 0.46% |
+5,000
| New | +$1.08M |
|
|
FAZE
13
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $518K | 0.22% |
3,126,319
| – | – |
|
|
CRON
14
Cronos Group
CRON
$1.06B
| $400K | 0.17% |
+200,000
| New | +$391K |
|
|
HITI
15
High Tide
HITI
$181M
| $139K | 0.06% |
+75,000
| New | +$107K |
|
|
16
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
| – | – |
-300,000
| Closed | -$1.66M |
|
|
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-50,673
| Closed | -$5.21M |
|
Similar funds
SC
HCM
SC
HBS
GIM
IFO
VG
CP
JW Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, JW Asset Management held 17 positions worth $231M, down 16% from $275M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
JW Asset Management deployed $16.2M of net new capital in Q3 2023, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was Vita Coco: 345,621 shares worth $9M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $5.21M sold.
- JW Asset Management's largest Q3 2023 buy was Vita Coco: 345,621 shares worth $9M.
- JW Asset Management added most to Celsius Holdings in Q3 2023, an estimated $1.51M increase.
- JW Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, selling an estimated $5.21M.
- JW Asset Management's ten largest holdings make up 99% of its $231M portfolio in Q3 2023.
- JW Asset Management opened 7 new positions and closed 2 in Q3 2023.
- JW Asset Management's portfolio value fell 16% quarter-over-quarter to $231M.
Based on JW Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.